Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Serzone superior to Prozac in the treatment of sleep disturbances in depressed patients

May 21, 1997

Excitatory amino acid antagonists disclosed by Glaxo Wellcome

May 21, 1997

Mitsubishi/Takeda codevelop new drug for AD

May 20, 1997

ADIR discloses compounds with high affinity for human D3 receptors

May 20, 1997

Cerebrovascular selectivity and vasospasmolytic action of AJ-3941

May 20, 1997

Krenitsky seeks partners for NGF modulators

May 19, 1997

Krenitsky seeks partners to develop MAO-A inhibitors

May 19, 1997

CoCensys enters licensing agreement with Wyeth-Ayerst for anxiety treatment

May 16, 1997

Briana Bio-Tech signs licensing agreement for chronic MS treatment

May 16, 1997

Cephalon and Chiron seek European approval of Myotrophin

May 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...